tiprankstipranks
Republic Healthcare Limited (HK:8357)
:8357
Hong Kong Market
Want to see HK:8357 full AI Analyst Report?

Republic Healthcare Limited (8357) AI Stock Analysis

0 Followers

Top Page

HK:8357

Republic Healthcare Limited

(8357)

Select Model
Select Model
Select Model
Neutral 43 (OpenAI - 5.2)
Rating:43Neutral
Price Target:
HK$0.10
▼(-19.17% Downside)
Action:Reiterated
Date:05/08/26
The score is weighed down primarily by weakening financial performance (worsening losses, negative operating/free cash flow, and higher debt). Technicals also remain soft with the price below major moving averages and negative MACD, while valuation is constrained by losses and no stated dividend support.
Positive Factors
Balance-sheet equity cushion
A sizable equity base and a history of conservative leverage (pre-2025) provide a durable solvency buffer that can absorb continued operating losses or permit measured refinancing. This improves the company’s ability to withstand stress and maintain operations over the next several months.
Negative Factors
Deteriorating profitability
Sustained gross and operating losses coupled with multi-year revenue declines signal weakening demand or pricing power and erode margins. Over months this reduces reinvestment capacity, increases reliance on external funding, and lowers visibility for returning to sustainable profitability.
Read all positive and negative factors
Positive Factors
Negative Factors
Balance-sheet equity cushion
A sizable equity base and a history of conservative leverage (pre-2025) provide a durable solvency buffer that can absorb continued operating losses or permit measured refinancing. This improves the company’s ability to withstand stress and maintain operations over the next several months.
Read all positive factors

Republic Healthcare Limited (8357) vs. iShares MSCI Hong Kong ETF (EWH)

Republic Healthcare Limited Business Overview & Revenue Model

Company Description
Republic Healthcare Limited, a primary healthcare services company, provides consultation, medical investigation, and treatment services in Singapore. The company offers various treatment solutions for common medical conditions and focuses on sexu...

Republic Healthcare Limited Financial Statement Overview

Summary
Overall financial quality is weak: revenue declined in 2025 and profitability deteriorated to a gross loss with large operating/net losses. Cash flow also turned negative in 2025 (operating and free cash flow), and debt increased sharply, raising financial risk despite a still-meaningful equity base.
Income Statement
22
Negative
Balance Sheet
54
Neutral
Cash Flow
28
Negative
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue8.51M7.84M9.23M10.28M9.44M13.97M
Gross Profit1.67M-23.92K6.48M2.70M5.97M9.13M
EBITDA-1.30M-1.76M-188.79K29.34K-387.88K962.89K
Net Income-1.25M-2.96M-178.16K-855.12K-1.48M-997.93K
Balance Sheet
Total Assets13.65M16.14M14.48M15.64M16.42M19.27M
Cash, Cash Equivalents and Short-Term Investments9.75M6.85M11.52M11.93M11.83M14.27M
Total Debt1.25M5.03M858.22K961.16K810.47K1.55M
Total Liabilities2.34M6.59M1.93M2.89M2.30M3.67M
Stockholders Equity11.31M9.55M12.55M12.75M14.12M15.59M
Cash Flow
Free Cash Flow-1.22M-3.12M51.27K806.24K-1.16M-1.13M
Operating Cash Flow-1.15M-1.90M125.07K899.91K-734.46K-510.07K
Investing Cash Flow1.24M-2.22M-93.94K831.49K-987.23K-1.56M
Financing Cash Flow-560.42K-813.99K-531.65K-587.62K-689.73K2.28M

Republic Healthcare Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.12
Price Trends
50DMA
0.13
Negative
100DMA
0.15
Negative
200DMA
0.15
Negative
Market Momentum
MACD
>-0.01
Positive
RSI
28.08
Positive
STOCH
-1.80
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:8357, the sentiment is Negative. The current price of 0.12 is above the 20-day moving average (MA) of 0.12, below the 50-day MA of 0.13, and below the 200-day MA of 0.15, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 28.08 is Positive, neither overbought nor oversold. The STOCH value of -1.80 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:8357.

Republic Healthcare Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
64
Neutral
HK$160.98M9.636.92%8.00%-17.36%-29.80%
58
Neutral
HK$47.61M-24.03-19.93%-2.91%55.41%
55
Neutral
HK$24.54M1.83138.68%-20.81%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
43
Neutral
HK$63.02M-3.40-27.01%-5.97%-1594.12%
42
Neutral
HK$114.98M-3.29-1449.22%-30.45%-734.38%
41
Neutral
HK$16.65M-1.0026.12%14.64%-81.95%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:8357
Republic Healthcare Limited
0.10
0.02
18.82%
HK:8143
Good Fellow Healthcare Holdings Limited
0.08
-0.04
-34.38%
HK:2293
Bamboos Health Care Holdings Ltd
0.40
-0.10
-20.00%
HK:8161
MediNet Group Ltd.
0.59
0.25
73.53%
HK:8307
Medicskin Holdings Ltd.
0.12
-0.05
-28.57%
HK:8437
RMH Holdings Limited
0.25
0.07
38.89%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: May 08, 2026